Mahnaz Ramezanpour

Dr. Mahnaz Ramezanpour

Post Doc

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Gohar ShaghayeghGohar Shaghayegh
Gohar Shaghayegh
CCClare Cooksley
Clare Cooksley
Mahnaz RamezanpourMahnaz Ramezanpour
Mahnaz Ramezanpour
PWPeter-John Wormald
Peter-John Wormald
APAlkis Psaltis
Alkis Psaltis
Sarah VreugdeSarah Vreugde
Sarah Vreugde
Chronic rhinosinusitis (CRS) is a persistent inflammation of the nasal cavity and paranasal sinuses associated with tissue remodelling, dysfunction of the sinuses’ natural defence mechanisms, and induction of different inflammatory clusters. The etiopathogenesis of CRS remains elusive, and both environmental factors, such as bacterial biofilms and the host’s general condition, are thought to play a role. Bacterial biofilms have significant clinical relevance due to their potential to cause resistance to antimicrobial therapy and host defenses. Despite substantial medical advances, some CRS patients suffer from recalcitrant disease that is unresponsive to medical and surgical treatments. Those patients often have nasal polyps with tissue eosinophilia, S. aureus-dominant mucosal biofilm, comorbid asthma, and a severely compromised quality of life. This review aims to summarise the contemporary knowledge of inflammatory cells/pathways in CRS, the role of bacterial biofilm, and their impact on the severity of the disease. Here, an emphasis is placed on S. aureus biofilm and its secreted products. A better understanding of these factors might offer important diagnostic and therapeutic perceptions for recalcitrant disease.

25 May 2021 in Allergy
Verified
Journal Article
Closed access
PDF file
JTJannatul Ferdoush Tuli
Jannatul Ferdoush Tuli
Mahnaz RamezanpourMahnaz Ramezanpour
Mahnaz Ramezanpour
CCClare Cooksley
Clare Cooksley
APAlkis James Psaltis
Alkis James Psaltis
PWPeter‐John Wormald
Peter‐John Wormald
Sarah VreugdeSarah Vreugde
Sarah Vreugde

4 October 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HHHua Hu
Hua Hu
Mahnaz RamezanpourMahnaz Ramezanpour
Mahnaz Ramezanpour
AHAndrew Hayes
Andrew Hayes
SHA LIUSHA LIU
SHA LIU
APAlkis Psaltis
Alkis Psaltis
Sarah VreugdeSarah Vreugde
Sarah Vreugde
Background: Chronic rhinosinusitis (CRS) is defined as a chronic inflammation of the nose and paranasal sinus mucosa associated with relapsing infections—particularly with S. aureus. Long-term treatments with protein synthesis inhibitor antibiotics have been proposed to reduce inflammation in the context chronic severe inflammatory airway pathologies, including CRS. This study assessed the effect of subinhibitory clindamycin and azithromycin on S. aureus exoprotein induced inflammation, toxicity and invasiveness. Methods: S. aureus ATCC51650 and two clinical isolates grown in planktonic and biofilm form were treated with subinhibitory clindamycin and azithromycin. Exoproteins were collected and applied to primary human nasal epithelial cells (HNECs) in monolayers and at air-liquid interface. This was followed by lactate dehydrogenase (LDH), enzyme-linked immunosorbent assay (ELISA), Transepithelial Electrical Resistance (TEER) and paracellular permeability assays to assess the effect on cell toxicity, inflammatory cytokine production and mucosal barrier structure and function, respectively. The effect of these treatments was tested as well on the S. aureus invasiveness of HNECs. Results: Subinhibitory clindamycin reduced S. aureus exoprotein production in planktonic and biofilm form, thereby blocking exoprotein-induced toxicity, reversing its detrimental effects on mucosal barrier structure and function and modulating its inflammatory properties. Sub-inhibitory azithromycin had similar effects—albeit to a lesser extent. Furthermore, clindamycin—but not azithromycin—treated S. aureus lost its invasive capacity of HNECs. Conclusion: Subinhibitory clindamycin and azithromycin reduce S. aureus exoprotein production, thereby modulating the inflammatory cascade by reducing exoprotein-induced toxicity, inflammation, mucosal barrier disruption and invasiveness.

1 June 2020 in Rhinology journal
Verified
Journal Article
Open access
MSM. Suzuki
M. Suzuki
Mahnaz RamezanpourMahnaz Ramezanpour
Mahnaz Ramezanpour
CCClare Cooksley
Clare Cooksley
TLT.J. Lee
T.J. Lee
BJBae Kwon Jeong
Bae Kwon Jeong
Sarah VreugdeSarah Vreugde
Sarah Vreugde
Zinc plays an important role in many biological processes. Reduced zinc levels have been found in chronic rhinosinusitis (CRS) patients, however, its role in the pathophysiology of this disease remains unknown. This study examined zinc levels in the serum, mucus and tissue from CRS patients in relation to collagen content and eosinophil infiltration. The effect of zinc depletion on inflammatory cytokine production and collagen synthesis was assessed in vitro. Zinc levels were determined in serum, mucus and tissue from controls, CRS with (CRSwNP) and without nasal polyps (CRSsNP) patients. Tissue zinc levels, collagen and inflammatory cell infiltration was examined using zinquin assays, immunofluorescence and histology on Tissue Micro Arrays. Cytokine expression and collagen synthesis was evaluated in zinc depleted primary human nasal epithelial cells (HNECs) and primary fibroblasts. CRSwNP patients showed reduced tissue zinc levels in correlation with a reduction in collagen content, and increased eosinophil numbers. Zinc depletion of HNECs and fibroblasts induced the production of pro-inflammatory cytokines and MUC5AC and reduced collagen secretion. These results suggest mucosal zinc depletion associates with tissue eosinophilia and collagen depletion in CRSwNP and induces pro-inflammatory cytokine expression and reduction of collagen synthesis in vitro.

16 August 2022 in Biology Open
Verified
Journal Article
Open access
PDF file
Mahnaz RamezanpourMahnaz Ramezanpour
Mahnaz Ramezanpour
HBHarrison Bolt
Harrison Bolt
KHKaren Hon
Karen Hon
Gohar ShaghayeghGohar Shaghayegh
Gohar Shaghayegh
HRHadi Rastin
Hadi Rastin
Sarah VreugdeSarah Vreugde
Sarah Vreugde
Patient-derived organoids grown in three-dimensional cultures provide an excellent platform for phenotypic high-throughput screening and drug-response research. Organoid technology has been applied to study stem cell biology and various human pathologies. This study investigates the characteristics and cellular morphology of organoids derived from primary human nasal epithelial cells (HNECs) of chronic rhinosinusitis (CRS) patients. Nasal organoids were cultured up to 20 days and morphological, cell composition and functional parameters were measured by immunofluorescence, RT-qPCR, western blot and FACS analysis. The results showed that nasal organoids expressed the stem cell marker leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), and markers for apical junction genes, goblet cells and ciliated cells. Moreover, we were able to regrow and expand the nasal organoids well after freezing and thawing. This study provides an effective and feasible method for development of human nasal organoids, suitable for the phenotypic high-throughput screening and drug response research.

28 June 2019 in Allergy
Verified
Journal Article
Closed access
PDF file
SKStephen Shih‐Teng Kao
Stephen Shih‐Teng Kao
Mahnaz RamezanpourMahnaz Ramezanpour
Mahnaz Ramezanpour
ABAhmed Bassiouni
Ahmed Bassiouni
JFJohn Finnie
John Finnie
PWPeter‐John Wormald
Peter‐John Wormald
APAlkis Psaltis
Alkis Psaltis